Barclays’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-124
| Closed | – | – | 4630 |
|
|
2017
Q4 | $0 | Hold |
124
| – | – | ﹤0.01% | 4393 |
|
|
2017
Q3 | $0 | Sell |
124
-100
| -45% | – | ﹤0.01% | 4357 |
|
|
2017
Q2 | $0 | Sell |
224
-3,931
| -95% | – | ﹤0.01% | 4369 |
|
|
2017
Q1 | $5K | Buy |
4,155
+4,116
| +10,554% | +$4.95K | ﹤0.01% | 3660 |
|
|
2016
Q4 | $0 | Sell |
39
-30
| -43% | – | ﹤0.01% | 4243 |
|
|
2016
Q3 | $0 | Hold |
69
| – | – | ﹤0.01% | 4307 |
|
|
2016
Q2 | $0 | Sell |
69
-3,096
| -98% | – | ﹤0.01% | 4187 |
|
|
2016
Q1 | $0 | Sell |
3,165
-6,627
| -68% | – | ﹤0.01% | 4031 |
|
|
2015
Q4 | $10K | Sell |
9,792
-122,221
| -93% | -$125K | ﹤0.01% | 2828 |
|
|
2015
Q3 | $924K | Buy |
132,013
+114,534
| +655% | +$802K | ﹤0.01% | 1443 |
|
|
2015
Q2 | $122K | Sell |
17,479
-34,021
| -66% | -$237K | ﹤0.01% | 2285 |
|
|
2015
Q1 | $411K | Sell |
51,500
-77,185
| -60% | -$616K | ﹤0.01% | 2013 |
|
|
2014
Q4 | $1.16M | Sell |
128,685
-42,770
| -25% | -$385K | ﹤0.01% | 1578 |
|
|
2014
Q3 | $1.54M | Buy |
171,455
+28,808
| +20% | +$259K | ﹤0.01% | 1489 |
|
|
2014
Q2 | $2.43M | Buy |
142,647
+43,415
| +44% | +$738K | ﹤0.01% | 1267 |
|
|
2014
Q1 | $1.69M | Sell |
99,232
-151,269
| -60% | -$2.57M | ﹤0.01% | 1410 |
|
|
2013
Q4 | $4.51M | Sell |
250,501
-51,144
| -17% | -$921K | ﹤0.01% | 1041 |
|
|
2013
Q3 | $7.84M | Sell |
301,645
-124,953
| -29% | -$3.25M | 0.01% | 703 |
|
|
2013
Q2 | $7.87M | Buy |
+426,598
| New | +$7.87M | 0.01% | 679 |
|